(OCGN) – Momentum Movers
-
Ocugen (OCGN) Spikes 20% After FDA Removes Clinical Hold on Phase 2/3 Clinical Trial for COVAXIN
-
Ocugen (OCGN) Falls 27% as FDA Declines to Issue EUA for its COVID-19 Vaccine
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OCGN Stock Lookup